Is ADEN.TO undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of ADENTRA Inc (ADEN.TO) is 193.69 CAD. This ADEN.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 27.81 CAD, the upside of ADENTRA Inc is 596.50%. This means that ADEN.TO is undervalued by 596.50%.
The range of the Intrinsic Value is 129.63 - 350.99 CAD
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 129.63 - 350.99 | 193.69 | 596.5% |
DCF (Growth 10y) | 159.81 - 391.61 | 227.36 | 717.5% |
DCF (EBITDA 5y) | 71.20 - 89.37 | 78.38 | 181.8% |
DCF (EBITDA 10y) | 112.66 - 142.91 | 125.33 | 350.7% |
Fair Value | 67.47 - 67.47 | 67.47 | 142.61% |
P/E | 27.91 - 30.37 | 28.68 | 3.1% |
EV/EBITDA | 24.78 - 37.24 | 30.03 | 8.0% |
EPV | 74.65 - 103.96 | 89.30 | 221.1% |
DDM - Stable | 18.30 - 45.67 | 31.98 | 15.0% |
DDM - Multi | 62.47 - 120.58 | 82.24 | 195.7% |
Market Cap (mil) | 697.20 |
Beta | 0.88 |
Outstanding shares (mil) | 25.07 |
Enterprise Value (mil) | 1,567.56 |
Market risk premium | 5.10% |
Cost of Equity | 10.82% |
Cost of Debt | 7.01% |
WACC | 7.46% |